Introducing Dx:Revenue - Precision Medicine Intelligence for Business Development Teams

LEARN MORE
Posts From the monthly archives: "March 2014"

For the first time we will be including clinical trial data in our updated research report,¬†Commercial Trends for Biomarker-Based IVD Tests, and here is an early look at some data describing how biomarkers are being used in drug development. Biomarker Use by Trial Phase For clinical trials registered in 2013, biomarkers are being…(Read More)

We have recently been sharing with our investors the story around biomarkers and how they have moved from adolescence into a maturing and embedded aspect of clinical development and care. We can point to lots of market dynamics that signal this transformation, but there is perhaps no more compelling evidence for this being an enduring…(Read More)